We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Testosterone as the Missing Link Between Pesticides, Alzheimer Disease, and Parkinson Disease—Reply

Jason R. Richardson, MS, PhD1
[+] Author Affiliations
1Rutgers Robert Wood Johnson Medical School, Environmental and Occupational Health Sciences Institute, Piscataway, New Jersey
JAMA Neurol. 2014;71(9):1190. doi:10.1001/jamaneurol.2014.1814.
Text Size: A A A
Published online


In Reply The interest of Martins and Carruthers regarding our study on pesticide levels and Alzheimer disease1 is appreciated. The primary tenet of their letter relates to the hypothesis that the mechanism by which pesticide exposure may contribute to Alzheimer and Parkinson diseases is through an antitestosterone effect. This hypothesis appears to be based on several cited review articles suggesting that androgens may play a role in cognitive aging and in the etiology of Alzheimer disease. Furthermore, Martins and Carruthers cite an article from 20 years ago regarding the antiandrogenenic effects of dichlorodiphenyldichloroethylene (DDE).2 On close inspection of the article, the dose or levels of DDE required to produce modest effects on androgen receptor binding and antiandrogenic effects are orders of magnitude higher than the serum levels we observed in our study and much higher than those observed in studies of highly exposed populations. Additionally, recent studies reported that populations highly exposed to dichlorodiphenyltrichloroethane/DDE3,4 or men aged 18 to 51 years in the United States5 either have no change or slightly increased levels of testosterone. Thus, although testosterone deficiency may well contribute to cognitive deficits and perhaps Alzheimer disease, the likelihood it contributes to the relationship between DDE and Alzheimer disease is exceedingly small. However, future studies are required to conclusively rule out an association between DDE levels, low testosterone, and Alzheimer disease. In our prior studies, we found no relationship between DDE and Parkinson disease.6,7


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





September 1, 2014
Ralph Martins, AO, PhD; Malcolm Carruthers, MD, FRCPath
1McCusker Alzheimer’s Research Foundation, Edith Cowan University, Nedlands, Australia
JAMA Neurol. 2014;71(9):1189-1190. doi:10.1001/jamaneurol.2014.795.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...